HomeVYNE • NASDAQ
add
Vyne Therapeutics Inc
Previous close
$1.68
Day range
$1.63 - $1.85
Year range
$1.59 - $4.30
Market cap
25.37M USD
Avg Volume
74.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 84.00K | 10.53% |
Operating expense | 12.85M | 86.07% |
Net income | -12.02M | -94.28% |
Net profit margin | -14.31K | -75.78% |
Earnings per share | — | — |
EBITDA | -12.77M | -87.39% |
Effective tax rate | -0.03% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 61.52M | -34.03% |
Total assets | 66.90M | -31.51% |
Total liabilities | 14.82M | 65.58% |
Total equity | 52.09M | — |
Shares outstanding | 15.21M | — |
Price to book | 0.48 | — |
Return on assets | -44.62% | — |
Return on capital | -55.12% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -12.02M | -94.28% |
Cash from operations | -9.00M | -75.18% |
Cash from investing | 12.74M | 120.43% |
Cash from financing | -132.00K | -100.16% |
Net change in cash | 3.61M | -76.23% |
Free cash flow | -4.78M | -47.98% |
About
Founded
2003
Headquarters
Website
Employees
13
